Cardiac Electrophysiology استشاري كهرباء القلب @orlandohealth | Alum @WeillCornell @JohnsHopkins @ClevelandClinic | #AI #Wearables | Tweets are my own opinions
Sep 1, 2019 • 11 tweets • 5 min read
1/ Today, at #ESCcongress2019 DAPA-HF trial showed amazing results. I love the complex story behind developing these novel #diabetes drugs and their impact on CVD so I'm going to share it in this tweetorial #cardiotwitter2/ First let me start by sharing DAPA-HF results. Basically, in pts with HFrEF, Dapagliflozin (SGLT-2i) arm had 26% reduction in primary outcome & 18% reduction in CV death REGARDLESS of #diabetes. Link to tweet w/results thx to @rladeiraslopes
